| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/25/1996 | EP0733039A1 Substituted pyrroloanthracenes and pyrroloanthracene diones as immunomodulators |
| 09/25/1996 | EP0733035A1 Tricyclic derivatives, pharmaceutical compositions containing them |
| 09/25/1996 | EP0733033A1 Pharmaceutically active substituted aromatic compounds |
| 09/25/1996 | EP0732943A1 Three-step pretargeting methods and compounds |
| 09/25/1996 | EP0732942A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists |
| 09/25/1996 | EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions |
| 09/25/1996 | EP0732940A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
| 09/25/1996 | EP0732938A1 Method of treating intestinal disorders |
| 09/25/1996 | EP0732935A1 Lyophilized stem cell factor formulations |
| 09/25/1996 | EP0732932A1 Use of urinastatin-like compounds to prevent premature delivery |
| 09/25/1996 | EP0732929A1 Therapeutic use of cis-element decoys in vivo |
| 09/25/1996 | EP0732928A1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
| 09/25/1996 | EP0732927A1 Compositions containing in particular, riboflavin, for the local prevention of diseases of the genital and rectal mucus membranes |
| 09/25/1996 | EP0732926A1 Pharmaceutical formulation for preventing or pre-treating poisoning by organophosphoric cholinesterase inhibitors |
| 09/25/1996 | EP0732925A1 A method of treating gastrointestinal motility disorders |
| 09/25/1996 | EP0732924A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent |
| 09/25/1996 | EP0732923A1 Pharmaceutical compositions containing hiv protease inhibitors |
| 09/25/1996 | EP0732922A1 Transdermal delivery device |
| 09/25/1996 | EP0732921A1 C-glycoside analogues of n-(4-hydroxyphenyl)retinamide-o-glucuronide |
| 09/25/1996 | EP0732920A1 Therapeutic agents containing thyroid hormones |
| 09/25/1996 | EP0732919A1 Diphenyl-2-propenoates and homologs thereof useful for treating diseases associated with leukotriene b4 |
| 09/25/1996 | EP0732918A1 Benzalkonium fluoride injectable solution |
| 09/25/1996 | EP0732917A1 Nutritional supplement for optimizing cellular health |
| 09/25/1996 | EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 09/25/1996 | EP0674513B1 Retroviral protease inhibiting compounds |
| 09/25/1996 | EP0650373B1 Sustained release alginate fibre and process for the preparation thereof |
| 09/25/1996 | EP0630233B1 Composition for oral preparations |
| 09/25/1996 | EP0569386B1 Bridged cyclic ketal derivatives |
| 09/25/1996 | EP0502925B1 Composition for treating inflammatory bowel disorders |
| 09/25/1996 | EP0458829B1 Methods and compositions for treatment of cancer using oligonucleotides |
| 09/25/1996 | EP0423221B1 Immunosuppressive agents |
| 09/25/1996 | CN1131949A Condensed indole derivatives as 5-HT4-receptor antagonists |
| 09/25/1996 | CN1131946A Distamycin A analogues as antitumour or antiviral agents |
| 09/25/1996 | CN1131942A HIV protease inhibitors |
| 09/25/1996 | CN1131939A Oxidizer carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and antitumor agents |
| 09/25/1996 | CN1131912A Compositions for topical treatment of erectile impotence |
| 09/25/1996 | CN1131911A Anthracyclinone derivatives and their use in amyloidosis |
| 09/25/1996 | CN1131910A Effervescent system with alkali-and/or metal-sensitive pharmaceutical active substance and process for producing the same |
| 09/25/1996 | CN1131907A Skin patches and methods for providing testosterone |
| 09/25/1996 | CN1131696A Enriched vinegar product and method of making the same |
| 09/25/1996 | CN1131675A Grosslinked acidic polysaccharides and their uses |
| 09/25/1996 | CN1131669A Optically active benzothiepin derivative, its preparation and use |
| 09/25/1996 | CN1131666A Tricyclic pyrazole derivatives |
| 09/25/1996 | CN1131665A Piperazine derivatives, medicaments comprising these compounds, their use and processes for their preparation |
| 09/25/1996 | CN1131664A New highly selective process for preparation of enantiomerically fure phenylsubstituted 1,4-dihydropyidine-3,5-dicarboxylic acid derivatives |
| 09/25/1996 | CN1131540A Preparation method of medicine for curing syphilopathy |
| 09/25/1996 | CN1131539A Treatment of disease and conditions associated with macrophage infiltration |
| 09/25/1996 | CN1131538A Pharmaceutical composition for oral administration of flavonoids |
| 09/25/1996 | CN1131537A Compound antidiarrheal |
| 09/25/1996 | CN1032858C Preparing method of methylamino pterin derivatives |
| 09/25/1996 | CN1032856C Process for the preparation of novel ccylals of imidazole-5-carboxylic acid derivatives |
| 09/25/1996 | CN1032842C Process for preparing preservation cornea |
| 09/25/1996 | CN1032841C Method for preparing antiacid effervescent couples |
| 09/25/1996 | CA2171518A1 Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides |
| 09/24/1996 | US5559269 Anticholinergic agents |
| 09/24/1996 | US5559258 Ethylenically unsaturated bile acid derivatives, processes for their preparation and precursors |
| 09/24/1996 | US5559256 Aminediol protease inhibitors |
| 09/24/1996 | US5559250 Treating red blood cell solutions with anti-viral agents |
| 09/24/1996 | US5559249 7'-amino-naphthazarin antibiotic derivatives |
| 09/24/1996 | US5559248 For prevention and treatment of skin disorders |
| 09/24/1996 | US5559246 Indole derivatives |
| 09/24/1996 | US5559238 N-substituted trifluoromethylphenyltetrahydropyridenes process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them |
| 09/24/1996 | US5559232 Anticoagulants |
| 09/24/1996 | US5559230 Vasopressin antagonists, quinolines, benzazepines, vasodilation, hypotensive agents |
| 09/24/1996 | US5559228 Synthesis of bisindolylmaleimides |
| 09/24/1996 | US5559227 Carbamates of rapaycin |
| 09/24/1996 | US5559225 7-acyl-3-(substituted carbamoyloxy) cephem compound |
| 09/24/1996 | US5559224 Carbepenem derivatives |
| 09/24/1996 | US5559222 Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose |
| 09/24/1996 | US5559213 Polyethylene-protein conjugates |
| 09/24/1996 | US5559211 Biologically active product produced by streptococcus pyogenes and method of purification |
| 09/24/1996 | US5559158 Pharmaceutical composition |
| 09/24/1996 | US5559157 Acetate, nicotinate or succinate, sorbic acid preservative |
| 09/24/1996 | US5559156 Method for treating animals infected with Babesia spp. |
| 09/24/1996 | US5559154 Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 09/24/1996 | US5559153 Antiarrhythmia agents; cardiovascular disorders |
| 09/24/1996 | US5559152 Pharmaceutical composition having antiacoholic activity |
| 09/24/1996 | US5559151 Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers |
| 09/24/1996 | US5559149 Skin care compositions containing retinoids |
| 09/24/1996 | US5559148 Parenteral busulfan for treatment of malignant disease |
| 09/24/1996 | US5559143 Anxiolytics, antidepressants, hypotensive agents, treatment of migraine |
| 09/24/1996 | US5559141 Selective aromatase inhibiting 4(5)-imidazoles |
| 09/24/1996 | US5559140 Difluoro statone analogs |
| 09/24/1996 | US5559139 Antiischemic agents, microcirculation |
| 09/24/1996 | US5559138 Method of Treating Glaucoma Using Oxadiazolyl or Thiadiazolyl Tetrahydropyridines |
| 09/24/1996 | US5559137 Pyrazoles, arthritis treatment |
| 09/24/1996 | US5559136 Treatment of Alzheimer's disease using azacyclic compounds |
| 09/24/1996 | US5559133 Orally active antiviral compounds |
| 09/24/1996 | US5559132 Carboxamide derivatives for treating asthma |
| 09/24/1996 | US5559131 Antagonists of tachykinins at the neurokinin 2 receptor, antiasthma |
| 09/24/1996 | US5559130 Pyrrolidinyl pyridones for treating pain |
| 09/24/1996 | US5559129 Indole derivatives |
| 09/24/1996 | US5559127 Fibrinogen receptor antagonists |
| 09/24/1996 | US5559126 Analgesics, antipsychotic agents |
| 09/24/1996 | US5559125 Nmda and ampa receptor antagonists, schizophrenia |
| 09/24/1996 | US5559124 Depolarizing skeletal muscle relaxants |
| 09/24/1996 | US5559123 Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same |
| 09/24/1996 | US5559122 Hindered N-oxide esters of rapamycin |
| 09/24/1996 | US5559121 Rapamycin formulations for oral administration |
| 09/24/1996 | US5559120 Immunosuppressants, antiinflammatory agents, fungicides and antitumor agents |